Investing
Also, five digital health projects are sharing almost $1 million in funding for their respective pilots.
The company will use the funds to accelerate its growth, expand the use of its models for different conditions and open an office in Cambridge.
Thyme Care secures $60 million in Series B funding, and Neuspera Medical garners $23 million.
If investment patterns in the first half of 2024 persist, this year could exceed year-end totals seen in 2019 and 2023, according to Rock Health's H1 2024 digital health funding report.
Unseen Capital funds entrepreneurs of early-stage healthcare companies focused on addressing the needs of underserved communities.
The company will use the funds to expand its workforce, including its sales team, in order to broaden its biopharma partnerships.
The funding comes a year after the company announced an expanded relationship with OpenAI to develop a chatbot for healthcare providers built on GPT-4.
It has also received Australia's regulatory approval for its AI solution.
The company will use the investment to expand its reach across the U.S. and develop new technologies.
Also, New Zealand's The Doctors has cautioned the public about a mobile app posing as its official app.